Reaction between bis(cyclopentadienyl)dimethylzirconium, ZrCp(2)(CH(3))(2), and phenylboronic anhydride, (PhBO)(3), resulted in the formation of the heterocyclic dimer [ZrCp(2)[mu-O(2)BPh]](2) (1); no reaction was observed with the mesityl derivative, (mesBO)(3). Compound 1 was also synthesized from the protonolysis reaction between ZrCp(2)(CH(3))(2) and in situ generated phenylboronic acid, PhB(OH)(2). This approach was extended to afford the analogous complexes [ZrCp(2)[mu-O(2)BAr]](2) (2, Ar = mes; 3, Ar = C(6)F(5)) from the corresponding isolable arylboronic acids, ArB(OH)(2). The molecular structures of 1-3, determined by X-ray diffraction techniques, revealed a common, dimeric motif consisting of a central "Zr(2)B(2)O(4)" metallacycle. Variations in the bond parameters within the heterocycle are attributed to the differing steric and electronic properties of the aryl substituents at boron.
No takes yet. Share an insight, caveat, or question.
Balkwill et al. (2002) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: